Department of Dermatology, Weill Cornell Medical College, New York, New York.
JAMA Dermatol. 2018 Feb 1;154(2):216-218. doi: 10.1001/jamadermatol.2017.5175.
This medical record review examines the novel use of low-dose trifluoperazine, a high-potency typical antipsychotic, in a cohort of patients with Morgellons disease.
本病历回顾研究考察了低剂量三氟拉嗪(一种高效典型抗精神病药)在一组患有莫吉隆斯病患者中的新用途。